IO Combinations 360° Overview in 7 Minutes

Kate Woda, IO Combinations 360° Conference Director, gives a 7 minute overview on what you can expect at the 5th annual IO Combinations 360° conference taking place October 1-2 virtually.

2020 Key Topics:

• Discovery / Preclinical Science
• Bispecifics
• Translational Science & Biomarkers
• Next Generation Cell Therapy
• Clinical Developments
• Operationalizing Combinations
• Business Aspects
• Emerging Technologies

Keynotes Include:

• Ronald Germain, MD, PhD, National Institutes of Health
• Steve Hamilton, Melanoma Cancer Survivor
• Edward Tenthoff, Piper Sandler & Co.

2020 Strategic Leadership:

• Dan Chen, MD, PhD, IGM Biosciences
• Axel Hoos, MD, PhD, GSK
• Alexandra Snyder, MD, Merck Research Labs
• Omid Hamid, MD, The Angeles Clinic and Research Institute
• Raluca Verona, PhD, Janssen R&D
• James Gulley, MD, PhD, National Cancer Institute, NIH
• Theresa LaVallee, PhD, Parker Institute for Cancer Immunotherapy
• Roy Baynes, MD, PhD, Merck Research Labs
• Michael Kalos, PhD, ArsenalBio

Learn more about the upcoming IO Combinations 360° virtual conference at www.iocombinations360.com